Bio-Techne (TECH) Tops Q4 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bio-Techne Releases Fourth Quarter Fiscal 2020 Results
August 4, 2020 6:30 AM EDTMINNEAPOLIS, Aug. 4, 2020 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2020.
Fourth Quarter FY2020 Snapshot
Fourth quarter organic revenue decreased 8% (-8% reported) to $175.8 million. Full year organic growth of 4% (4% reported) to $738.7 million. GAAP EPS was $1.48 vs. $0.42 one year ago. Delivered adjusted earnings per share (EPS) of $1.00 vs. $1.25 one year ago. Full year GAAP EPS was $5.82 vs $2.47 one year ago. Full year adjusted EPS was $4.55 vs $4.51 in the prior year. Maintained strong operating... More